The Experts below are selected from a list of 184767 Experts worldwide ranked by ideXlab platform
Shizukiyo Ishikawa - One of the best experts on this subject based on the ideXlab platform.
-
Soy and Soy Products Intake, All-Cause Mortality, and Cause-Specific Mortality in Japan The Jichi Medical School Cohort Study
Asia-Pacific journal of public health, 2014Co-Authors: Kyoko Yamasaki, Kazunori Kayaba, Shizukiyo IshikawaAbstract:Soy and soy products are popular ingredients in the Japanese diet. This study aimed to determine whether soy or soy products intake was associated with all-cause mortality in a community-based cohort in Japan. A total of 11 066 participants were obtained from an annual community-based health examination program. A self-administered questionnaire was used to collect information concerning soy and soy products intake and potential confounding factors. Associations between soy and soy products intake and all-cause mortality were assessed using hazard ratios (HRs). After adjusting for all factors, Morality was significantly higher in men with infrequent soy intake (HR = 1.53; 95% confidence interval [CI] = 1.13-2.07) and with almost daily intake (HR = 1.55; 95% CI = 1.19-2.03) compared with intake 1 to 2 times per week. Cancer mortality was higher among men who reported rarely eating soy (HR = 1.74; 95% CI = 1.08-2.79). Soy products intake was not statistically significantly associated with all-cause mortality in both sexes.
Emmanuel Villar - One of the best experts on this subject based on the ideXlab platform.
-
survival advantage of hemodialysis relative to peritoneal dialysis in patients with end stage renal disease and congestive heart failure
Kidney International, 2011Co-Authors: Florence Sens, Annemarie Schottpethelaz, M Labeeuw, Cyrille Colin, Emmanuel VillarAbstract:Peritoneal dialysis (PD) has been proposed as a therapeutic option for patients with end-stage renal disease and associated congestive heart failure (CHF). Here, we compare mortality risks in these patients by dialysis modality by including all patients who started planned chronic dialysis with associated congestive heart failure and were prospectively enrolled in the French REIN Registry. Survival was compared between 933 PD and 3468 hemodialysis (HD) patients using a Kaplan–Meier model, Cox regression, and propensity score analysis. The patients were followed from their first dialysis session and stratified by modality at day 90 or last modality if death occurred prior. There was a significant difference in the median survival time of 20.4 months in the PD group and 36.7 months in the HD group (hazard ratio, 1.55). After correction for confounders, the adjusted hazard ratio for death in PD compared to the HD patients remained significant at 1.48. Subgroup analyses showed that the results were not changed with regard to the New York Heart Association stage, age strata, or estimated glomerular filtration rate strata at first renal replacement therapy. The use of propensity score did not change results (adjusted hazard ratio, 1.55). Thus, mortality risk was higher with PD than with HD among incident patients with end-stage renal disease and congestive heart failure. These results may help guide clinical decisions and also highlight the need for randomized clinical trials.
-
survival advantage of hemodialysis relative to peritoneal dialysis in patients with end stage renal disease and congestive heart failure
Kidney International, 2011Co-Authors: Florence Sens, Annemarie Schottpethelaz, M Labeeuw, Cyrille Colin, Emmanuel VillarAbstract:Peritoneal dialysis (PD) has been proposed as a therapeutic option for patients with end-stage renal disease and associated congestive heart failure (CHF). Here, we compare mortality risks in these patients by dialysis modality by including all patients who started planned chronic dialysis with associated congestive heart failure and were prospectively enrolled in the French REIN Registry. Survival was compared between 933 PD and 3468 hemodialysis (HD) patients using a Kaplan–Meier model, Cox regression, and propensity score analysis. The patients were followed from their first dialysis session and stratified by modality at day 90 or last modality if death occurred prior. There was a significant difference in the median survival time of 20.4 months in the PD group and 36.7 months in the HD group (hazard ratio, 1.55). After correction for confounders, the adjusted hazard ratio for death in PD compared to the HD patients remained significant at 1.48. Subgroup analyses showed that the results were not changed with regard to the New York Heart Association stage, age strata, or estimated glomerular filtration rate strata at first renal replacement therapy. The use of propensity score did not change results (adjusted hazard ratio, 1.55). Thus, mortality risk was higher with PD than with HD among incident patients with end-stage renal disease and congestive heart failure. These results may help guide clinical decisions and also highlight the need for randomized clinical trials.
Kyoko Yamasaki - One of the best experts on this subject based on the ideXlab platform.
-
Soy and Soy Products Intake, All-Cause Mortality, and Cause-Specific Mortality in Japan The Jichi Medical School Cohort Study
Asia-Pacific journal of public health, 2014Co-Authors: Kyoko Yamasaki, Kazunori Kayaba, Shizukiyo IshikawaAbstract:Soy and soy products are popular ingredients in the Japanese diet. This study aimed to determine whether soy or soy products intake was associated with all-cause mortality in a community-based cohort in Japan. A total of 11 066 participants were obtained from an annual community-based health examination program. A self-administered questionnaire was used to collect information concerning soy and soy products intake and potential confounding factors. Associations between soy and soy products intake and all-cause mortality were assessed using hazard ratios (HRs). After adjusting for all factors, Morality was significantly higher in men with infrequent soy intake (HR = 1.53; 95% confidence interval [CI] = 1.13-2.07) and with almost daily intake (HR = 1.55; 95% CI = 1.19-2.03) compared with intake 1 to 2 times per week. Cancer mortality was higher among men who reported rarely eating soy (HR = 1.74; 95% CI = 1.08-2.79). Soy products intake was not statistically significantly associated with all-cause mortality in both sexes.
Rajnish Mehrotra - One of the best experts on this subject based on the ideXlab platform.
-
dialysis modality and correction of uremic metabolic acidosis relationship with all cause and cause specific mortality
Clinical Journal of The American Society of Nephrology, 2013Co-Authors: Tania Vashistha, Kamyar Kalantarzadeh, Miklos Z Molnar, Klara Torlen, Rajnish MehrotraAbstract:Summary Background and objectives Uremic metabolic acidosis is only partially corrected in many hemodialysis patients, and low serum bicarbonate predicts higher death risk. This study determined the comparative efficacy of peritoneal dialysis in correcting uremic metabolic acidosis and the association of serum bicarbonate and death risk with the two therapies. Design, setting, participants, & measurements Data were obtained from 121,351 prevalent ESRD patients (peritoneal dialysis, 10,400; hemodialysis, 110,951) treated in DaVita facilities between July 1, 2001 and June 30, 2006, with follow-up through June of 2007. Results Serum bicarbonate was Conclusions The measured bicarbonate is significantly higher in peritoneal dialysis patients, suggesting that the therapy provides a more complete correction of metabolic acidosis than intermittent hemodialysis. Survival data suggest maintaining serum bicarbonate>22 mEq/L for all ESRD patients, irrespective of dialysis modality.
Vincent L. Smith - One of the best experts on this subject based on the ideXlab platform.
-
sr450 and superhawk xp applications of bacillus thuringiensis israelensis against culex quinquefasciatus
Journal of The American Mosquito Control Association, 2014Co-Authors: James C Dunford, Craig A. Stoops, Alden S. Estep, Seth C. Britch, Alec G. Richardson, Todd W. Walker, Muahmmad Farooq, David F. Hoel, Raymond R Platt, Vincent L. SmithAbstract:Abstract Sprayer comparisons and larval Morality assays were conducted following SR450 backpack mist blower and Superhawk XP thermal fogger applications of Vectobac® WDG Bacillus thuringiensis israelensis (Bti) against Culex quinquefasciatus. Bacillus thuringiensis israelensis was applied at maximum label rate in a 232.26-m2 field plot located in north-central Florida with containers placed at 2 heights (ground level and 1.52 m above ground) on stakes positioned 3.04, 6.09, 9.14, 12.19, and 15.24 m from the spray line. Results indicated that there was no significant (P > 0.05) difference in 24- and 48-h larval mortality between the 2 sprayers or between the 2 heights. There was significant difference (P 70% larval mortality 3.04–9.14 m from the spray line, and <60% mortality at 12.19 and 15.24 m. The data suggest that the SR450 and Superhawk XP may be comparable spraye...
-
SR450 And Superhawk XP Applications Of Bacillus thuringiensis israelensis Against Culex quinquefasciatus.
Journal of the American Mosquito Control Association, 2014Co-Authors: James C Dunford, Craig A. Stoops, Alden S. Estep, Seth C. Britch, Alec G. Richardson, Todd W. Walker, Muahmmad Farooq, David F. Hoel, Raymond R Platt, Vincent L. SmithAbstract:Abstract Sprayer comparisons and larval Morality assays were conducted following SR450 backpack mist blower and Superhawk XP thermal fogger applications of Vectobac® WDG Bacillus thuringiensis israelensis (Bti) against Culex quinquefasciatus. Bacillus thuringiensis israelensis was applied at maximum label rate in a 232.26-m2 field plot located in north-central Florida with containers placed at 2 heights (ground level and 1.52 m above ground) on stakes positioned 3.04, 6.09, 9.14, 12.19, and 15.24 m from the spray line. Results indicated that there was no significant (P > 0.05) difference in 24- and 48-h larval mortality between the 2 sprayers or between the 2 heights. There was significant difference (P 70% larval mortality 3.04–9.14 m from the spray line, and